3 news items
Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease
CGTX
21 May 24
neurodegenerative disorders, has released its eighth Conversations video podcast episode: "Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's Disease
CGTX
22 Apr 24
president and CEO. "They reinforced the importance of removing toxic oligomers as an important step in slowing the progress of Alzheimer's disease
Cognition Therapeutics Presents Analyses at AD/PD™ 2024 Correlating Proteomic Findings with Treatment Effect of CT1812 in Alzheimer's Disease Studies
CGTX
6 Mar 24
with published evidence that the normalization of aberrant pathways can protect neurons from toxic disease drivers. Further, we believe they support our
- Prev
- 1
- Next